Launch One Acquisition Corp. Class A Ordinary shares
LPAA
Launch One Acquisition Corp is a blank check company.
Last trade$0.00
Day change$0.00 (0.00%)
Day range$10.86 – $11.05
Volume8
Market cap$83M
OpenXNAS
Fundamentals
Key company ratios and reported financial statements.
Source: Massive.com
Key ratios
No ratio data was found for LPAA.
Financial statements
Income and cash flow amounts are for the period; balance sheets are point-in-time
snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are
displayed when available.
No quarterly
income statement data was found for LPAA.
Recent news
Company coverage with links to the original publishers.
Minovia Therapeutics announced the grant of two new U.S. patents (No. 12,502,408 and No. 12,329,781) covering its proprietary Mitochondrial Augmentation Therapy (MAT) platform for treating primary mitochondrial diseases and renal diseases. The patents, with corresponding grants in Europe and Japan, strengthen the company's intellectual property portfolio. Minovia's lead program MNV-201, currently in clinical trials for Pearson Syndrome, consists of autologous hematopoietic stem cells enriched with placental-derived mitochondria. The company is proceeding with a business combination with Launch One Acquisition Corp., expected to close in the first half of 2026.
Minovia Therapeutics received FDA Orphan Drug Designation for MNV-201, a novel cell therapy targeting Myelodysplastic Syndrome (MDS), and announced a planned business combination with Launch One Acquisition Corp.
Minovia Therapeutics received FDA Fast Track Designation for MNV-201, its investigational compound targeting Myelodysplastic Syndrome (MDS), potentially accelerating drug development and review process.
Minovia Therapeutics, a clinical-stage biotechnology company, and Launch One Acquisition Corp., a SPAC, have announced a proposed business combination to create a Nasdaq-listed mitochondrial therapy company focused on rare diseases and longevity.
Dividends
Declared distributions and recorded event dates. Forecasts are not
shown.
Updated daily
No declared upcoming dividend found.
No prior dividend records found.
Stock splits
Historical share-structure events and their execution dates.